Ownership history in MPM BioImpact LLC · 12 quarters on record
This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Relay Therapeutics Inc. (RLAY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 2,232,451 | -50,229 | -2.2% | 2.16% | $18.9M | $8.46 |
| 2025 Q3 | UNCHANGED | 2,282,680 | — | 0% | 1.95% | $11.9M | $5.22 |
| 2025 Q2 | REDUCED | 2,282,680 | -13,244 | -0.6% | 1.37% | $7.9M | $3.46 |
| 2025 Q1 | ADDED | 2,295,924 | +27,099 | +1.2% | 1.03% | $6.0M | $2.62 |
| 2024 Q4 | ADDED | 2,268,825 | +235,784 | +11.6% | 1.33% | $9.3M | $4.12 |
| 2024 Q3 | ADDED | 2,033,041 | +758,582 | +59.5% | 2.16% | $14.4M | $7.08 |
| 2024 Q2 | ADDED | 1,274,459 | +442,442 | +53.2% | 1.29% | $8.3M | $6.52 |
| 2024 Q1 | UNCHANGED | 832,017 | — | 0% | 1.11% | $6.9M | $8.30 |
| 2023 Q4 | REDUCED | 832,017 | -520,116 | -38.5% | 2.14% | $9.2M | $11.01 |
| 2023 Q3 | REDUCED | 1,352,133 | -2,235 | -0.2% | 3.04% | $11.4M | $8.41 |
As of 2025 Q4 — sorted by position size